Igor Astsaturov
Impact in
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer-related Molecular Pathways
- Lung Cancer Research Studies
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
- Oncology 46
- Pancreatic and Hepatic Oncology Research 14
- Cancer-related Molecular Pathways 10
- Colorectal Cancer Treatments and Studies 8
- HER2/EGFR in Cancer Research 7
- Lung Cancer Research Studies 7
- Co-authors
- Erica A. Golemis (17 shared papers)Ilya G. Serebriiskii (11 shared papers)Linara Gabitova (7 shared papers)Anna S. Nikonova (1 shared paper)Roland L. Dunbrack (1 shared paper)Andrey Gorin (3 shared papers)Barbara Burtness (12 shared papers)Steven J. Cohen (19 shared papers)
- Journals
- Journal of Clinical Oncology (20 papers)British Journal of Cancer (5 papers)Clinical Cancer Research (5 papers)Cancer Research (5 papers)Molecular Cancer Therapeutics (4 papers)
- Partner nations
- United StatesRussiaCanada
In The Last Decade
Igor Astsaturov
95 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 111
- Oncology 958
- Cancer Research 411
- Cell Biology 382
- Molecular Biology 1.1k
- Immunology 304
Countries citing papers authored by Igor Astsaturov
This map shows the geographic impact of Igor Astsaturov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Astsaturov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Astsaturov more than expected).
Fields of papers citing papers by Igor Astsaturov
This network shows the impact of papers produced by Igor Astsaturov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Astsaturov. The network helps show where Igor Astsaturov may publish in the future.
Co-authors
The 25 scholars most cited alongside Igor Astsaturov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 343 | |
| 2 | 2013 | 112 | |
| 3 | 2010 | 107 | |
| 4 | 1998 | 97 | |
| 5 | 2010 | 93 | |
| 6 | 2010 | 89 | |
| 7 | 2009 | 87 | |
| 8 | 2016 | 82 | |
| 9 | 2001 | 75 | |
| 10 | 2012 | 75 | |
| 11 | 2017 | 74 | |
| 12 | 2011 | 71 | |
| 13 | 2015 | 63 | |
| 14 | 2020 | 60 | |
| 15 | 2009 | 60 | |
| 16 | 2007 | 60 | |
| 17 | 2006 | 56 | |
| 18 | 2013 | 56 | |
| 19 | 2014 | 55 | |
| 20 | 2018 | 54 |
About Igor Astsaturov
Igor Astsaturov is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 97 papers that have together received 2.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (14 papers), Lung Cancer Treatments and Mutations (13 papers), Cancer-related Molecular Pathways (10 papers), Microtubule and mitosis dynamics (9 papers), Cancer Genomics and Diagnostics (9 papers), Colorectal Cancer Treatments and Studies (8 papers), HER2/EGFR in Cancer Research (7 papers) and Lung Cancer Research Studies (7 papers). The work is most often cited by research in Oncology (958 citations), Cancer Research (411 citations), Cell Biology (382 citations), Molecular Biology (1.1k citations) and Immunology (304 citations). Igor Astsaturov has collaborated with scholars based in United States, Russia and Canada. Frequent co-authors include Erica A. Golemis, Ilya G. Serebriiskii, Linara Gabitova, Anna S. Nikonova, Roland L. Dunbrack, Andrey Gorin, Barbara Burtness, Steven J. Cohen, Crystal S. Denlinger and Paul M. Harari. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Clinical Cancer Research, Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.